Evidence map›Paper›PMID 29316961›Full record

ReviewParasites & vectors2018

Combating Acanthamoeba spp. cysts: what are the options?

Ayaz Anwar, Naveed Ahmed Khan, Ruqaiyyah Siddiqui

Abstract readReview
In one paragraph

Review in Parasites & vectors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. High prevalence ofParasite epidemiology and control · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Anti-Scientifica · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Induction of Programmed Cell Death inAntioxidants (Basel, Switzerland) · 2023
    Article
  16. Do antidiabetic drugs prevent the transformation ofPathogens and global health · 2023
    Article
  17. Microorganisms · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ayaz AnwarDepartment of Biological Sciences, School of Science and Technology, Sunway University, Subang Jaya, Malaysia.
Naveed Ahmed KhanDepartment of Biological Sciences, School of Science and Technology, Sunway University, Subang Jaya, Malaysia. naveed5438@gmail.com.
Ruqaiyyah SiddiquiDepartment of Biological Sciences, School of Science and Technology, Sunway University, Subang Jaya, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acanthamoeba spp. are protist pathogens and causative agents of serious infections including keratitis and granulomatous amoebic encephalitis. Its ability to convert into dormant and highly resistant cysts form limits effectiveness of available therapeutic agents and presents a pivotal challenge for drug development. During the cyst stage, Acanthamoeba is protected by the presence of hardy cyst walls, comprised primarily of carbohydrates and cyst-specific proteins, hence synthesis inhibition and/or degradation of cyst walls is of major interest. This review focuses on targeting of Acanthamoeba cysts by identifying viable therapeutic targets.

Indexed as

AcanthamoebaAmebiasisAntiprotozoal AgentsDrug DiscoveryHumansSpores, ProtozoanAntiprotozoal AgentsAcanthamoebaCystEncystationExcystationTherapeutic targets

Identifiers

PMID29316961
PMCPMC5759203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.